anmelden
FTSE All-Share
5.832,63
PKT
+38,13
PKT
+0,66
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.01.23 | HSBC Buy | UBS AG | |
| 18.01.23 | Rio Tinto Sell | UBS AG | |
| 18.01.23 | HSBC Outperform | RBC Capital Markets | |
| 17.01.23 | Diageo Buy | Goldman Sachs Group Inc. | |
| 17.01.23 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 17.01.23 | Rio Tinto Underweight | JP Morgan Chase & Co. | |
| 17.01.23 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 17.01.23 | Rio Tinto Underweight | JP Morgan Chase & Co. | |
| 17.01.23 | Unilever Underperform | Bernstein Research | |
| 16.01.23 | HSBC Buy | Deutsche Bank AG | |
| 16.01.23 | Prudential Buy | Jefferies & Company Inc. | |
| 13.01.23 | Glencore Buy | UBS AG | |
| 13.01.23 | Unilever Sell | UBS AG | |
| 12.01.23 | HSBC Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.01.23 | Glencore Overweight | Barclays Capital | |
| 12.01.23 | Rio Tinto Equal Weight | Barclays Capital | |
| 12.01.23 | Rio Tinto Outperform | Credit Suisse Group | |
| 12.01.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 12.01.23 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 12.01.23 | Diageo Sell | Deutsche Bank AG | |
| 12.01.23 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.01.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 11.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.01.23 | BAT Overweight | JP Morgan Chase & Co. | |
| 11.01.23 | Glencore Outperform | RBC Capital Markets | |
| 11.01.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 11.01.23 | Unilever Neutral | Goldman Sachs Group Inc. | |
| 10.01.23 | BAT Overweight | JP Morgan Chase & Co. | |
| 10.01.23 | Prudential Buy | Deutsche Bank AG | |
| 10.01.23 | Rio Tinto Hold | Deutsche Bank AG | |
| 10.01.23 | Glencore Buy | Deutsche Bank AG | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Buy | Deutsche Bank AG | |
| 09.01.23 | GSK Equal Weight | Barclays Capital | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 09.01.23 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 09.01.23 | GSK Sell | UBS AG |
